1-9 of 9
Rogier Versteeg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A30: NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome

Michael Hölzel, Sidong Huang, Jan Koster, Ingrid Ora, Arjan Lakeman, H. N. Caron, Tom Callens, Jing Xie, Wouter Nijkamp, Shahab Asgharzadeh, Robert C. Seeger, Ludwine Messiaen, Rogier Versteeg, Rene Bernards
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): A30.
https://doi.org/10.1158/1078-0432.TCME10-A30
Published: 02 February 2016
View article titled, Abstract A30: NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome
Journal Articles

Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma

M. Emmy M. Dolman, Evon Poon, Marli E. Ebus, Ilona J.M. den Hartog, Carel J.M. van Noesel, Yann Jamin, Albert Hallsworth, Simon P. Robinson, Kevin Petrie, Rolf W. Sparidans, Robbert J. Kok, Rogier Versteeg, Huib N. Caron, Louis Chesler, Jan J. Molenaar
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (22): 5100–5109.
https://doi.org/10.1158/1078-0432.CCR-15-0313
Published: 12 November 2015
View article titled, Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma
Open the PDF for Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

A NOTCH3 Transcriptional Module Induces Cell Motility in Neuroblastoma

Johan van Nes, Alvin Chan, Tim van Groningen, Peter van Sluis, Jan Koster, Rogier Versteeg
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (13): 3485–3494.
https://doi.org/10.1158/1078-0432.CCR-12-3021
Published: 30 June 2013
View article titled, A NOTCH3 Transcriptional Module Induces Cell Motility in Neuroblastoma
Open the PDF for A NOTCH3 Transcriptional Module Induces Cell Motility in Neuroblastoma in another window
Includes: Multimedia, Supplementary data
Journal Articles

Mutations in the Ras–Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer

Kristel Kemper, Miranda Versloot, Katherine Cameron, Selçuk Colak, Felipe de Sousa e Melo, Joan H. de Jong, Joanne Bleackley, Louis Vermeulen, Rogier Versteeg, Jan Koster, Jan Paul Medema
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (11): 3132–3141.
https://doi.org/10.1158/1078-0432.CCR-11-3066
Published: 31 May 2012
View article titled, Mutations in the Ras–Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer
Open the PDF for Mutations in the Ras–Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Methylated RASSF1a Is the First Specific DNA Marker for Minimal Residual Disease Testing in Neuroblastoma

Janine Stutterheim, Fatima Ait Ichou, Emmy den Ouden, Rogier Versteeg, Huib N. Caron, Godelieve A.M. Tytgat, C. Ellen van der Schoot
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3): 808–814.
https://doi.org/10.1158/1078-0432.CCR-11-0849
Published: 31 January 2012
View article titled, Methylated RASSF1a Is the First Specific DNA Marker for Minimal Residual Disease Testing in Neuroblastoma
Open the PDF for Methylated RASSF1a Is the First Specific DNA Marker for Minimal Residual Disease Testing in Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples

Katleen De Preter, Pieter Mestdagh, Joëlle Vermeulen, Fjoralba Zeka, Arlene Naranjo, Isabella Bray, Victoria Castel, Caifu Chen, Elzbieta Drozynska, Angelika Eggert, Michael D. Hogarty, Ewa Iżycka-Swieszewska, Wendy B. London, Rosa Noguera, Marta Piqueras, Kenneth Bryan, Benjamin Schowe, Peter van Sluis, Jan J. Molenaar, Alexander Schramm, Johannes H. Schulte, Raymond L. Stallings, Rogier Versteeg, Geneviève Laureys, Nadine Van Roy, Frank Speleman, Jo Vandesompele
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (24): 7684–7692.
https://doi.org/10.1158/1078-0432.CCR-11-0610
Published: 18 December 2011
View article titled, miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples
Open the PDF for miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples in another window
Includes: Supplementary data
Journal Articles

Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

Sara De Brouwer, Katleen De Preter, Candy Kumps, Piotr Zabrocki, Michaël Porcu, Ellen M. Westerhout, Arjan Lakeman, Jo Vandesompele, Jasmien Hoebeeck, Tom Van Maerken, Anne De Paepe, Geneviève Laureys, Johannes H. Schulte, Alexander Schramm, Caroline Van Den Broecke, Joëlle Vermeulen, Nadine Van Roy, Klaus Beiske, Marleen Renard, Rosa Noguera, Olivier Delattre, Isabelle Janoueix-Lerosey, Per Kogner, Tommy Martinsson, Akira Nakagawara, Miki Ohira, Huib Caron, Angelika Eggert, Jan Cools, Rogier Versteeg, Frank Speleman
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (17): 4353–4362.
https://doi.org/10.1158/1078-0432.CCR-09-2660
Published: 31 August 2010
View article titled, Meta-analysis of Neuroblastomas Reveals a Skewed <em>ALK</em> Mutation Spectrum in Tumors with <em>MYCN</em> Amplification
Open the PDF for Meta-analysis of Neuroblastomas Reveals a Skewed <em>ALK</em> Mutation Spectrum in Tumors with <em>MYCN</em> Amplification in another window
Includes: Supplementary data
Journal Articles

Molecular Risk Stratification of Medulloblastoma Patients Based on Immunohistochemical Analysis of MYC, LDHB, and CCNB1 Expression

Talitha de Haas, Nancy Hasselt, Dirk Troost, Huib Caron, Mara Popovic, Lorna Zadravec-Zaletel, Wieslawa Grajkowska, Marta Perek, Maria-Chiara Osterheld, David Ellison, Frank Baas, Rogier Versteeg, Marcel Kool
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (13): 4154–4160.
https://doi.org/10.1158/1078-0432.CCR-07-4159
Published: 01 July 2008
View article titled, Molecular Risk Stratification of Medulloblastoma Patients Based on Immunohistochemical Analysis of MYC, LDHB, and CCNB1 Expression
Open the PDF for Molecular Risk Stratification of Medulloblastoma Patients Based on Immunohistochemical Analysis of MYC, LDHB, and CCNB1 Expression in another window
Includes: Supplementary data
Journal Articles

Expression of Prenylated Rab Acceptor 1 Domain Family, Member 2 (PRAF2) in Neuroblastoma: Correlation with Clinical Features, Cellular Localization, and Cerulenin-Mediated Apoptosis Regulation

Dirk Geerts, Christopher J. Wallick, Dana-Lynn T. Koomoa, Jan Koster, Rogier Versteeg, Ramon Christopher V. Go, André S. Bachmann
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (21): 6312–6319.
https://doi.org/10.1158/1078-0432.CCR-07-0829
Published: 01 November 2007
View article titled, Expression of Prenylated Rab Acceptor 1 Domain Family, Member 2 (PRAF2) in Neuroblastoma: Correlation with Clinical Features, Cellular Localization, and Cerulenin-Mediated Apoptosis Regulation
Open the PDF for Expression of Prenylated Rab Acceptor 1 Domain Family, Member 2 (PRAF2) in Neuroblastoma: Correlation with Clinical Features, Cellular Localization, and Cerulenin-Mediated Apoptosis Regulation in another window
Includes: Supplementary data